FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV – ViiV Healthcare
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced the FDA approved Dovato (dolutegravir/lamivudine) for the treatment of HIV-1… read more.
